Anuh Pharma Limited

BSE:506260 Stok Raporu

Piyasa değeri: ₹9.8b

Anuh Pharma Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 5/6

Anuh Pharma has been growing earnings at an average annual rate of 22.9%, while the Pharmaceuticals industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 15.1% per year. Anuh Pharma's return on equity is 19.9%, and it has net margins of 9.3%.

Anahtar bilgiler

22.9%

Kazanç büyüme oranı

22.9%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi17.5%
Gelir büyüme oranı15.1%
Özkaynak getirisi19.9%
Net Marj9.3%
Sonraki Kazanç Güncellemesi08 Nov 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Anuh Pharma nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

BSE:506260 Gelir, gider ve kazançlar (INR Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 246,2345782110
31 Mar 246,4706012070
31 Dec 236,4045431970
30 Sep 236,0714451900
30 Jun 235,7264061850
31 Mar 235,2753621800
31 Dec 224,9913551740
30 Sep 224,9213361680
30 Jun 224,8583231620
31 Mar 224,8663061570
31 Dec 214,5482251520
30 Sep 214,2151931520
30 Jun 214,2501731540
31 Mar 214,3202841510
31 Dec 204,0692661520
30 Sep 203,8442881490
30 Jun 203,4632521370
31 Mar 203,0701431390
31 Dec 193,1802051360
30 Sep 193,1211961260
30 Jun 193,2532351220
31 Mar 193,2072341140
31 Dec 183,0472131210
30 Sep 182,9932081190
30 Jun 182,6651601140
31 Mar 182,3811651090
31 Dec 172,315161940
30 Sep 172,155194870
30 Jun 172,087193800
31 Mar 172,061201790
31 Dec 162,209181670
30 Sep 162,476191690
30 Jun 162,887217700
31 Mar 163,262258700
31 Dec 153,2612571390
30 Sep 153,1552611360
30 Jun 152,9522351320
31 Mar 152,837220590
31 Dec 142,8942271320
30 Sep 142,8992131280
30 Jun 142,8622071260
31 Mar 142,6641761230
31 Dec 132,4871491200

Kaliteli Kazançlar: 506260 has high quality earnings.

Büyüyen Kar Marjı: 506260's current net profit margins (9.3%) are higher than last year (7.1%).

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 506260's earnings have grown significantly by 22.9% per year over the past 5 years.

Büyüme Hızlandırma: 506260's earnings growth over the past year (42.4%) exceeds its 5-year average (22.9% per year).

Kazançlar vs. Sektör: 506260 earnings growth over the past year (42.4%) exceeded the Pharmaceuticals industry 19.1%.

Özkaynak Getirisi

Yüksek ROE: 506260's Return on Equity (19.9%) is considered low.

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y